As part of an agency-wide initiative to speed development of new medical products through the science of pharmacogenomics, the FDA has issued a final guidance regarding pharmacogenomic data submissions.
India’s government proposed on Friday to change the country’s patent laws to make it illegal to copy patented drugs, a practice that has made cheaper medicines available in India and abroad.
There could be as many as 50 new biotechnology medicines approved for commercial use in the coming months, thanks to advances in biotechnology research and development, according to a study released March 7.
For the second week in a row, buyout rumors and merger speculation sent a number of biotech and specialty pharmaceutical shares higher.
Ad executives and drug company officials say changes in advertising strategies are almost a certainty in the wake of the Vioxx and Celebrex news and new studies showing a consumer backlash.
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
Recent Comments